Aims: Hyperglycaemia, in stroke patients, is associated with worse neurological outcome by comprimising endothelial cell function and the blood-brain barrier (BBB) integrity. We have studied the contribution of hyperglycaemia-mediated generation of oxidative stress to these pathologies and examined whether antioxidants as well as normalisation of glucose levels following hyperglycaemic insult reverse these phenomena.
Introduction
Vascular endothelium covers the entire inner surface of all the blood vessels and is implicated in the regulation of vasomotor tone, cellular trafficking and the local balance between pro-and anti-inflammatory mediators [1, 2] . Endothelial cells in some organs differentiate and develop into specialised barriers to regulate vascular permeability. One such example is the blood-brain barrier (BBB) which stops the passage of substances from blood into the central nervous system. The BBB consists of brain microvascular endothelial cells (BMEC), capillary basement membranes and astrocyte end-feet. Astrocytes surround 99% of the BBB endothelia and release soluble factors to maintain the integrity of the BBB [3] . Since the brain oedema, associated with the BBB disruption, is more prevalent in stroke patients with diabetes mellitus than those without, it is safe to suggest that hyperglycaemia plays a prominent role in this defect [4] [5] [6] .
Diabetes mellitus is a metabolic disorder associated with microvascular complications.
Although several mechanisms including non-enzymatic glycation of proteins and lipids with the irreversible formation/deposition of advanced glycation end products (AGEs), the activation of polyol pathway, stimulation of protein kinase C (PKC) or oxidative stress accompanied by overproduction of reactive oxygen species (ROS) have been implicated in peripheral vascular pathologies [1] , the mechanisms by which hyperglycaemia exerts damage on brain microvasculature remain unknown.
The hyperglycaemia-mediated activation of PKC represents a hallmark in peripheral vasculopathies and is associated with increases in endothelial permeability, angiogenesis and ROS overproduction [7, 8] . ROS, in particular superoxide anion (O 2 .- ) increase vascular permeability in various disease models including focal ischaemia and impairs neuronal homeostasis and cerebrovascular tone [9, 10] . NAD(P)H oxidase, a pro-oxidant enzyme with a membrane-bound active core consisting of p22-phox and gp91-phox subunits, has been shown as the main enzymatic source of ROS in coronary EC exposed to hyperglycaemia [11] .
Under physiological conditions, once generated O 2 .-is neutralised by superoxide dismutases (SODs) to H 2 O 2 which in turn is metabolised to H 2 O by catalase and glutathione peroxidase (GPx).
Nitric oxide (NO), another ROS generated by endothelial NO synthase (eNOS), is also implicated in diabetic microvasculopathy and BBB hyperpermeability in cerebral pathologies such as middle cerebral artery occlusion where the NOS inhibitors (L-NNA and L-NAME)
have been shown to reduce both brain oedema and BBB damage [12] . However, physiological levels of NO are known to regulate cerebral blood flow, vascular tone and protect against ischaemic stroke by increasing collateral flow to the ischaemic area [13] . It is of note that endothelial cells represent the main cellular source of NO and O 2 .
-and the prevalence of diabetes is significantly greater in ischaemic stroke patients with small-vessel compared to large-artery diseases [14] .
It is well-documented that hyperglycaemia promotes a pro-coagulant state to compromise blood supply to the penumbral areas in acute ischaemic stroke (AIS) through, in part, increasing the expressions of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) [15] .
In the light of the currently available data, this study hypothesises that hyperglycaemia may perturb endothelial function and the BBB integrity by promoting oxidative stress and employing a variety of intermediary molecules. To this end, the present study was designed to investigate whether; i-changes in the expression and/or activities of oxidative stress related parameters i.e. adhesion molecules and pro-and antioxidant enzymes are involved in hyperglycaemia-mediated cerebral microvascular endothelial cell dysfunction, ii-exposure of HBMEC and human astrocytes (HA) co-cultures to normoglycaemia or hyperglycaemia distinctly modulate blood-brain barrier (BBB) integrity; iii-antioxidants and signal transduction pathway inhibitors can help in the maintenance of the BBB integrity during hyperglycaemic insult; iv-normalisation of glucose levels has favourable effects on the aforementioned parameters following hyperglycaemic insult.
Materials and Methods

Cell culture
HBMEC and HA were purchased from TCS Cellworks (Buckingham, UK) and cultured in specialised media. HA were characterised by glial fibrillary acidic protein (GFAP) staining while HBMEC were characterised by stainings for vWF/Factor VIII and CD31 (P-CAM) as well as by uptake of DiI-Ac-LDL. Cells were grown to subconfluence and incubated under normoglycaemic (NG; D-Glucose; 5.5 mM) and hyperglycaemic (HG; D-Glucose; 25 mM)
conditions for a period of five days. Cells were also cultured in equimolar concentrations of D-Mannitol (25 mM) to assess if the changes observed in enzyme activities or expressions were due to hyperosmolality rather than HG per se. In a sub-set of experiments HBMEC were initially cultured in hyperglycaemic conditions for 5 days followed by a further 5 days culture in normoglycaemic conditions to assess the specific effects of glucose normalisation on aforementioned oxidative stress-related biomarkers.
Evaluation of cell viability
To detect cytotoxicity of outlined treatment regimens, a small aliquot of cells were incubated in 0.1% trypan blue for 4 min and viewed under a light microscope. By counting 100 cells, the percentage of viable cells was calculated.
In vitro BBB co-culture model
HA were seeded on the outside of collagen-coated polycarbonate membrane (0.4 μM)
Transwell inserts (12-well type, Corning) directed upside down in the culture chamber. HA were allowed to adhere to the membrane overnight and then inverted the correct way.
HBMEC were seeded on the inside of the insert and cells were grown to confluence, to create the contact co-culture model. The non-contact model is a replica of the contact model but the astrocytes were seeded onto the bottom of the well as opposed to the underside of the Transwell insert. Co-cultures were incubated for a period of 72 h under NG, HG and HG in the presence of an antioxidant agent including vitamin C (0.5 μM), catalase (150 U/mL), a free radical scavenger (MnTBAP; 50 μM), a protein kinase C inhibitor i.e. bisindolyamide I (5 μM) or a MAPK inhibitor (SB203580; 10 μM). To investigate the extent of HA involvement in preservation of the BBB integrity under HG conditions, a monolayer of HBMEC were exposed to the aforementioned agents.
Measurement of BBB integrity
This was assessed by measuring transendothelial electrical resistance (TEER) across the membrane using STX electrodes and an EVOM resistance meter (World Precision Instruments, UK). Three independent readings were taken every 24 hours and blank filter measurements were subtracted from inserts seeded with cells. Values are shown as Ωcm 2 based on culture insert size. 
Measurement of NAD(P)H oxidase activity
Catalase Assay
Catalase activity was measured using an immunoassay kit (Merck Biosciences, UK). The assay was based on the reaction of catalase with optimal concentration of H 2 O 2 in the presence of methanol to produce formaldehyde and detect it spectrophotometrically using 4-amino-3-hydrazino-5-mercapto-1,2,4-triazole (Purpald) as the chromogen. Enzyme activities were then determined using a standard curve generated with formaldehyde. One unit was defined as the amount of enzyme that generates the formation of 1 nmol formaldehyde per min, at 25°C.
GPx Assay
GPx activity was measured using a specific immunoassay kit (Merck Biosciences, UK) based on the simultaneous reduction of glutathione and oxidation of NAD(P)H to NADP + , accompanied by a decrease in absorbance at 340 nm. GPx activities were then calculated using the extinction coefficient for NAD(P)H at 340 nm (0.00373 µM -1 
Western Blotting
Total cellular proteins were isolated by lysis and equal amounts of protein (50 μg) were run on 10% SDS-polyacrylamide gels. Proteins were transferred to nitrocellulose membranes prior to overnight incubation with monoclonal primary antibodies. Primary antibodies to catalase, MnSOD, CuZnSOD and GPx were obtained from Merck Biosciences. eNOS was from Transduction Laboratories while those for gp91-phox and p22-phox were from Autogen Bioclear. Horseradish peroxidase linked secondary antibodies were then used and the bands were detected by enhanced chemiluminescence (GE Healthcare). Blots were assessed by densitometry of bands with subtraction of the background counts measured outside loaded lanes.
Statistical Analysis
Results of molecular assays and TEER experiments are presented as mean  SEM.
Statistical analyses were performed by two-way analysis of variance (ANOVA) followed by Bonferroni-Dunn's post hoc analysis and p<0.05 was considered significant.
Results
Effects of hyperglycaemia on protein expression
HG produced significant increases in p22-phox, a subunit of NAD(P)H oxidase, eNOS, CuZnSOD, catalase and GPx protein expression in HBMEC without affecting that of MnSOD. Glucose normalisation following HG significantly decreased p22-phox, eNOS, catalase, and GPx protein levels ( Figure 1 ).
Effects of hyperglycaemia on pro-oxidant and antioxidant enzyme activities
Exposure of HBMEC to HG for 5 days resulted in a 2-fold increase in pro-oxidant NAD(P)H oxidase enzyme activity compared to cells grown under normoglycaemic conditions. Normalisation of glucose levels for a further 5-day period attenuated the effects of the hyperglycaemic insult (Table 1) .
Similar to NAD(P)H oxidase, the eNOS activity and nitrite levels, a breakdown product of NO production, also rose in HBMEC cultured under hyperglycaemic conditions which were subsequently reduced by glucose normalisation (Table 1) .
HG significantly enhanced CuZnSOD activity in HBMEC that was diminished by glucose normalisation where MnSOD activity appeared to be unaffected by HG (Table 1) .
Catalase activity was found to be significantly increased in hyperglycaemic HBMEC that was diminished with glucose normalisation. Although hyperglycaemia produced a slight increase in GPx activities, glucose normalisation caused a profound decrease in its activity (Table 1) .
Effects of hyperglycaemia on adhesion molecules
HG produced a significant increase in VCAM-1 but not ICAM-1 concentration. Glucose normalisation had no effect on ICAM-1 levels while significantly decreasing that of VCAM-1 compared to the HG group ( Figure 2 ).
Effects of different treatment regimens on cellular viability
No significant variations were observed in overall viability rates of HBMEC and HA cultured with HG, NG or hyperosmolar media ( Table 2) .
Effects of hyperglycaemia on TEER
As HA-HBMEC co-cultures produced better electrical resistance compared to non-contact and HBMEC monolayer models, this model has been used throughout the study to obtain statistically significant differences ( Other studies employing specific inhibitors of protein kinase C (Bisindolyamide I, 5 μM) and p38MAPK (SB203580, 10 μM) and PI3 kinase (LY29402, 50 μM) have shown that selective inhibitions of protein kinase C and p38MAPK but not PI3 kinase reverses HGinduced decreases in TEER readings ( Figure 6 ).
Discussion
The major conclusions to be drawn from this study are that hyperglycaemia compromises the BBB integrity through mechanisms mediated, in part, by oxidative stress and different signal transduction pathways. Indeed, specific inhibition of PKC or p38MAPK pathways, alleviation of oxidative stress by a series of functionally distinct antioxidants and normalisation of high glucose levels restore the BBB integrity.
Diabetes mellitus (DM) is a major risk factor for ischaemic stroke while hyperglycaemia without pre-existing diabetes is linked to a worse neurological outcome and stroke mortality [9, 16] . Brain oedema constitutes one of the main causes of death following stroke and is associated with the BBB disruption. Considering that the brain oedema is more prevalent in stroke patients with DM than those without, it is reasonable to suggest that HG plays a prominent role in this defect [4] [5] [6] . Ischaemic stroke develops through an interference with blood supply to the central nervous system and may be associated with oxidative stress i.e. an imbalance between ROS production and metabolism [17] . Although low level generation of ROS is critical for neuronal homeostasis, their excess generation, particularly by NAD(P)H oxidase, is implicated in vascular injuries and intracranial haemorrhage [18, 19] . Increases in certain NAD(P)H oxidase subunit expressions have been shown in STZ-induced diabetic rats with transient middle cerebral artery occlusion, an animal model of human ischaemic stroke and correlated with infarct sizes, more severe neurological deficits and brain oedema volume [20] . Significant increases in NAD(P)H oxidase enzyme activity and p22-phox protein expression, an integral NAD(P)H subunit, have also been found in this study in HBMEC cultured under hyperglycaemic conditions. Given that these increases were suppressed by normalisation of glucose levels, collectively these data shed some light on the mechanistic causes of HG-mediated increases of oxidative stress and subsequent endothelial dysfunction.
As deficiencies in MnSOD and/or CuZnSOD activities may also contribute to enhanced oxidative status, the expression and activities of these enzymes were explored in HBMEC exposed to HG which revealed no changes or significant increases in cases of MnSOD and CuZnSOD, respectively. Since HG significantly increases the BBB permeability, these data imply that the increase in CuZnSOD activity (~2-fold) which makes up~80% of total SOD activity [21] is not sufficient to quench the excessive ROS generated under hyperglycaemic conditions. In support of this hypothesis, the current study has shown that the concurrent protein expression in HBMEC exposed to HG which were reversed by glucose normalisation and consequent removal of HG-mediated oxidative insult. Similar to catalase, a slight but significant increase was also observed in GPx protein expression in cells cultured under hyperglycaemic conditions. However, the increase in protein levels was not translated into activity perhaps as a result of previously reported instability of the GPx complex over time in diabetic rat tissues including brain [23] .
NO, another ROS, has also been implicated in the BBB hyperpermeability in cerebral pathologies such as middle cerebral artery occlusion [12] . It is mainly generated by endothelial NO synthase (eNOS) whose activity and expression under diabetic conditions remain controversial in that both enhanced and diminished eNOS expressions have been inhibitors, respectively). These findings were in agreement with previous studies showing that SOD and catalase administrations reduce the tracer permeation to the cerebral ischemic brain in rats [30] [31] [32] .
The findings with the PKC inhibitor were, to a large degree, expected considering undisputed involvement of PKC activation in hyperglycaemia-mediated peripheral vasculopathies, ROS overproduction and cerebral endothelial dysfunction [7, 8, 33] . Protein kinase C may utilise two mechanisms to impair NO-mediated vasodilatation. Firstly, it may directly modify eNOS post-translationally via its dephosphorylation at Ser1177 and phosphorylation at Thr495 which together result in decreased NO production [34] . Secondly, protein kinase C may impair eNOS function indirectly through effects on NAD(P)H oxidase, the most potent generator of O 2 .-that rapidly scavenges NO. Similar to PKC, inhibition of p38MAPK has also been shown as neuroprotective in cerebral ischaemia [35, 36] . The p38 pathway may mediate neuronal damage by counteracting ERK signalling in models of apoptosis and free radical damage in vitro [38] , by controlling the release of granules in neutrophils in the process of inflammation [39] or by induction of cytokines [40] . However, contradictory reports with p38MAPK inhibitor also exist in that rats given SB203580 prior to transient middle cerebral artery occlusion have been shown to develop widespread cerebral lesions and vascular leakage [37] .
Research encompassing the PI3K inhibitor, LY29402 is very limited. However, Gottfried et al reported loss of polygonal morphology with varying degrees of stellation in rat hippocampal astrocytes treated with LY29402 [41] . This may have significance as intact brain astrocytic processes encounter and bind to collagen IV and laminin in the basement membrane of endothelial cells that surround cerebral capillaries and form the BBB [42] .
Concurrence between previously published data and our findings suggest that the potential therapies for hyperglycaemia in acute stroke patients should include treatment regimens that establish and maintain normoglycaemia. In support of this notion, a recent retrospective study of AIS patients showed that patients with an admission glucose level of >130mg/dl had increased mortality compared to those whose glucose levels were normalised within 48 hr [43] . In this context, another study has revealed that intensive intravenous insulin therapy to maintain NG reduce the risk of organ failure and death in surgical intensive care patients [44] .
In conclusion the current study has shown that HBMEC incubated with HG possess enhanced NAD(P)H oxidase enzyme activity and expression compared to cells grown under NG and that the reversal of HG to NG significantly suppress these increases. Secondly the increased production of free radicals by NAD(P)H oxidase through activation of different signal transduction pathways appear to compromise the integrity of the BBB under diabetic conditions. Effective reversal of high glucose levels exerts beneficial effects on the preservation of the BBB unity and may therefore be therapeutically beneficial in diabetic stroke patients. Percentage viable cells were determined by trypan blue exclusion experiments and counting 100 cells. Data are expressed as mean ± SEM from
